Logo image of PSNY

POLESTAR AUTOMOTIVE-CL A ADS (PSNY) Stock Fundamental Analysis

NASDAQ:PSNY - Nasdaq - US7311052010 - ADR - Currency: USD

1.07  -0.03 (-2.73%)

Premarket: 1.1 +0.03 (+2.8%)

Fundamental Rating

1

Taking everything into account, PSNY scores 1 out of 10 in our fundamental rating. PSNY was compared to 39 industry peers in the Automobiles industry. PSNY may be in some trouble as it scores bad on both profitability and health. PSNY is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

PSNY had negative earnings in the past year.
In the past year PSNY has reported a negative cash flow from operations.
In the past 5 years PSNY always reported negative net income.
PSNY had a negative operating cash flow in each of the past 5 years.
PSNY Yearly Net Income VS EBIT VS OCF VS FCFPSNY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -500M -1B -1.5B -2B

1.2 Ratios

PSNY has a worse Return On Assets (-50.56%) than 79.49% of its industry peers.
Industry RankSector Rank
ROA -50.56%
ROE N/A
ROIC N/A
ROA(3y)-29.97%
ROA(5y)-27.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PSNY Yearly ROA, ROE, ROICPSNY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PSNY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PSNY Yearly Profit, Operating, Gross MarginsPSNY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

0

2. Health

2.1 Basic Checks

PSNY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PSNY remains at a similar level compared to 1 year ago.
PSNY has a worse debt/assets ratio than last year.
PSNY Yearly Shares OutstandingPSNY Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
PSNY Yearly Total Debt VS Total AssetsPSNY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

PSNY has an Altman-Z score of -3.89. This is a bad value and indicates that PSNY is not financially healthy and even has some risk of bankruptcy.
PSNY has a worse Altman-Z score (-3.89) than 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.89
ROIC/WACCN/A
WACC8.3%
PSNY Yearly LT Debt VS Equity VS FCFPSNY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B

2.3 Liquidity

A Current Ratio of 0.48 indicates that PSNY may have some problems paying its short term obligations.
PSNY's Current ratio of 0.48 is on the low side compared to the rest of the industry. PSNY is outperformed by 76.92% of its industry peers.
A Quick Ratio of 0.26 indicates that PSNY may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.26, PSNY is doing worse than 74.36% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.48
Quick Ratio 0.26
PSNY Yearly Current Assets VS Current LiabilitesPSNY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1B 2B 3B 4B

5

3. Growth

3.1 Past

PSNY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -143.52%.
Looking at the last year, PSNY shows a decrease in Revenue. The Revenue has decreased by -3.81% in the last year.
The Revenue has been growing by 57.15% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-143.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-529.41%
Revenue 1Y (TTM)-3.81%
Revenue growth 3Y57.15%
Revenue growth 5YN/A
Sales Q2Q%8.35%

3.2 Future

PSNY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.85% yearly.
The Revenue is expected to grow by 34.91% on average over the next years. This is a very strong growth
EPS Next Y-36.52%
EPS Next 2Y-6.54%
EPS Next 3Y5.22%
EPS Next 5Y16.85%
Revenue Next Year-8.76%
Revenue Next 2Y27.97%
Revenue Next 3Y36%
Revenue Next 5Y34.91%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PSNY Yearly Revenue VS EstimatesPSNY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B
PSNY Yearly EPS VS EstimatesPSNY Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 -0.2 -0.4

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PSNY. In the last year negative earnings were reported.
Also next year PSNY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PSNY Price Earnings VS Forward Price EarningsPSNY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PSNY Per share dataPSNY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.54%
EPS Next 3Y5.22%

0

5. Dividend

5.1 Amount

PSNY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

POLESTAR AUTOMOTIVE-CL A ADS

NASDAQ:PSNY (5/28/2025, 8:00:00 PM)

Premarket: 1.1 +0.03 (+2.8%)

1.07

-0.03 (-2.73%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)N/A N/A
Inst Owners4.11%
Inst Owner Change-11.97%
Ins Owners62.98%
Ins Owner ChangeN/A
Market Cap2.26B
Analysts45
Price Target1.48 (38.32%)
Short Float %10.87%
Short Ratio10.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)2.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-18.75%
Revenue NY rev (1m)0%
Revenue NY rev (3m)23.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.11
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)-0.44
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.47
OCFYN/A
SpS0.96
BVpS-1.58
TBVpS-2.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -50.56%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-29.97%
ROA(5y)-27.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 678.93%
Cap/Sales 18.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.48
Quick Ratio 0.26
Altman-Z -3.89
F-Score1
WACC8.3%
ROIC/WACCN/A
Cap/Depr(3y)542.43%
Cap/Depr(5y)358.86%
Cap/Sales(3y)23.96%
Cap/Sales(5y)24.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-143.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-529.41%
EPS Next Y-36.52%
EPS Next 2Y-6.54%
EPS Next 3Y5.22%
EPS Next 5Y16.85%
Revenue 1Y (TTM)-3.81%
Revenue growth 3Y57.15%
Revenue growth 5YN/A
Sales Q2Q%8.35%
Revenue Next Year-8.76%
Revenue Next 2Y27.97%
Revenue Next 3Y36%
Revenue Next 5Y34.91%
EBIT growth 1Y-20.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.08%
EBIT Next 3Y36.15%
EBIT Next 5Y30.43%
FCF growth 1Y44.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.66%
OCF growth 3YN/A
OCF growth 5YN/A